New drug confirmed as a potential therapeutic agent for a rare disease, Friedreich's Ataxia

by IRB Lleida. Institut de Recerca Biomèdica

A recent study has confirmed the benefits of the drug leriglitazone in treating Friedrich's Ataxia, a rare disease that affects 2-4 people in 100,000 and for which there is currently no effective cure...

Read more

Next Stop, the Clinic - Preparing your new Drug for Clinical Research with SciFindern and Formulus®

by CAS, a division of the American Chemical Society

Things are going well for your latest drug molecule - it seems efficacious, you have assessed potential toxicity, and even determined a safe starting dose, and now you are ready to move to the clinic...

Read more

Sant Pau participates in a phase 2 study that achieves positive results on a drug to combat the cognitive complications of Parkinson’s

by Hospital de la Santa Creu i Sant Pau

Dr. Kulisevsky, director of the Movement Disorders Unit of the Sant Pau Hospital Neurology Service and head of the Parkinson’s Disease and Movement Disorders Research Group at the Sant Pau Research ...

Read more

The drug SAR405, the best inhibitor of autophagy

by IRB Lleida. Institut de Recerca Biomèdica

UdL research questions use of 3-methyladenine in studies because of its toxicity

Read more

SOM Biotech announces poster presentation on the repurposing of Eravacycline for the treatment of SARS-CoV-2

by Som Biotech

SOM Biotech announces today that it will present in silico and in vitro results regarding Eravacycline for the treatment of SARS-CoV-2 during a virtual poster presentation at the IDWeek 2020.

Read more

ORYZON publishes paper in Journal of Clinical Oncology demonstrating relevance of iadademstat in leukemia

by Oryzon Genomics

Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, announces the p...

Read more

Metoprolol: an old drug with unique cardioprotective properties

by Centro Nacional de Investigaciones Cardiovasculares - CNIC

CNIC scientists have defined the unique ability if metoprolol to protect the heart during a heart attack

Read more

Promega Developing OncoMate™ MSI Assay as Companion Diagnostic for Endometrial Cancer Drug Candidate from Incyte

by Promega Biotech Ibérica

Promega Corporation announced today its intent to develop the Promega OncoMate™ microsatellite instability (MSI) Assay as a companion diagnostic test for retifanlimab, Incyte’s anti-PD-1 drug cand...

Read more

Palobiofarma announces positive results from the Phase II clinical trial evaluating the preliminary efficacy and safety of its adenosine A1 receptor antagonist PBF-680 in mild to moderate asthmatics patients

by Palobiofarma

The results confirm a clinically and statistically significant improvement in trough FEV1 of asthmatic patients taking 10mg of PBF-680 for 14 days compared to placebo.

Read more

Identification of 6-amino-1H-pyrazolo[3,4-d]pyrimidines with in vivo efficacy against visceral leishmaniasis

by Galchimia

We are happy to share our latest report from the work carried out in collaboration with GlaxoSmithKline and the Drug Discovery Unit of the University of Dundee. The paper published in RSC Medicinal Ch...

Read more

SOM Biotech is awarded a grant from CDTI to start clinical trials with a drug inhibitor of SARS- COV-2 replication

by Som Biotech

SOM B​iotechhas been granted €340,000.00 from the Center for Industrial Te​chnological Development (CDTI, Spain), within the extraordinary call for grants for R&D projects to face the COVID-19 h...

Read more

Promising drug against non-alcoholic steatohepatitis, a severe type of liver disease

by Fundació Bosch i Gimpera

Nonalcoholic steatohepatitis (NASH) affects 2 to 5 percent of the world’s population. It is the most severe form of fatty liver disease, which can lead to cirrhosis, among other complications, and i...

Read more
Subscribe to Directory
Write an Article

Recent News

Tuneable reverse photochromes in the sol...

A new technique allows the design of solid materia...

La Unidad de Chequeos de la Clínica sup...

El estudio realizado sobre una muestra significati...

Highlight

Interview with Dámaso Molero, general m...

by 3P Biopharmaceuticals

Dámaso Molero: “There are great opportunities in Latin America for ...

La adquisición de acciones de IntegraGe...

by OncoDNA

Onco​DNA, compañía especializada en medicina de precisión para el...

Photos Stream